Tracheal intubating conditions using sevoflurane and remifentanil target-controlled infusions without muscle relaxant.

Tracheal intubating conditions using sevoflurane and remifentanil target-controlled infusions without muscle relaxant. - tracheal intubating conditions with remifentanil TCI.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019648

Enrollment

Registered

2015-11-05

Start date

2015-11-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

otological patients without muscle relaxant

Interventions

remifentanil TCI 15 ng/ml(effect site concentration) remifentanil TCI 10 ng/ml(effect site concentration) remifentanil TCI 5 ng/ml(effect site concentration)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: otological patients without muscle relaxant

Exclusion criteria

Exclusion criteria: Patients who refuse to participate this study Patients who have severe cardiovascular disease

Design outcomes

Primary

Measure	Time frame
Intubating score Blood pressure, heart rate of intubation Dose of vasopressor agent	—

Countries

Japan

Contacts

Public ContactManabu Yoshimura

Tokuyama Central Hospital Department of Anesthesiology

manabu-ygc@umin.ac.jp0834-22-4411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026